{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:28:32Z","timestamp":1791757712964,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04040-8","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T11:36:11Z","timestamp":1738323371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis with prolonged hyperammonemia: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Chunxia","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonglei","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"4","key":"4040_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al. AMPA Receptor Antibodies in Limbic Encephalitis Alter synaptic receptor location. Ann Neurol. 2009;65(4):424\u201334.","journal-title":"Ann Neurol"},{"issue":"1","key":"4040_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12028-016-0370-7","volume":"27","author":"G Harutyunyan","year":"2017","unstructured":"Harutyunyan G, Hauer L, Dunser MW, Karamyan A, Moser T, Pikija S, et al. Autoimmune encephalitis at the neurological intensive care unit: etiologies, reasons for admission and Survival[J]. Neurocrit Care. 2017;27(1):82\u20139.","journal-title":"Neurocrit Care"},{"key":"4040_CR3","first-page":"931","volume":"9","author":"J Wang","year":"2022","unstructured":"Wang J, Guan H, Zhao G. Chinese expert consensus on the diagnosis and management of autoimmune encephalitis(2022 edition). Chin J Neurol. 2022;9:931\u201349.","journal-title":"Chin J Neurol"},{"key":"4040_CR4","doi-asserted-by":"publisher","first-page":"665229","DOI":"10.3389\/fneur.2021.665229","volume":"12","author":"K Wang","year":"2021","unstructured":"Wang K, Shi Y, Du Q, Zhang R-r, Wu H, Qiao S, et al. Clinical Review and prognostic analysis of\u03b1-Amino-3-Hydroxy-5-Methyl-4-Isoxazole propionate receptor-Associated Encephalitis. Front Neurol. 2021;12:665229.","journal-title":"Front Neurol"},{"issue":"2","key":"4040_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","volume":"266","author":"O Laurido-Soto","year":"2019","unstructured":"Laurido-Soto O, Brier MR, Simon LE, McCullough A, Bucelli RC, Day GS. Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol. 2019;266(2):450\u201360.","journal-title":"J Neurol"},{"issue":"24","key":"4040_CR6","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology. 2015;84(24):2403\u201312.","journal-title":"Neurology"},{"key":"4040_CR7","doi-asserted-by":"publisher","first-page":"652820","DOI":"10.3389\/fimmu.2021.652820","volume":"12","author":"TY Zhang","year":"2021","unstructured":"Zhang TY, Cai MT, Zheng Y, Lai QL, Shen CH, Qiao S, et al. Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: a review. Front Immunol. 2021;12:652820.","journal-title":"Front Immunol"},{"issue":"4","key":"4040_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neuron.2017.04.009","volume":"94","author":"IH Greger","year":"2017","unstructured":"Greger IH, Watson JF, Cull-Candy SG. Structural and Functional Architecture of AMPA-Type glutamate receptors and their auxiliary proteins. Neuron. 2017;94(4):713\u201330.","journal-title":"Neuron"},{"issue":"1","key":"4040_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","volume":"100","author":"H Haselmann","year":"2018","unstructured":"Haselmann H, Mannara F, Werner C, Planagum\u00e0 J, Miguez-Cabello F, Schmidl L, et al. Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction. Neuron. 2018;100(1):91\u2013105. e9.","journal-title":"Neuron"},{"issue":"3","key":"4040_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62(3):405\u201396.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"4040_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/0028-3886.310087","volume":"69","author":"VR Ashok","year":"2021","unstructured":"Ashok VR, Nagabushana D, Yashwanth G, Mahadevan A, Netravathi M. A rare case of wobbly, psychotic patient with frozen eyes-anti-AMPA receptor encephalitis. Neurol India. 2021;69(1):149\u201352.","journal-title":"Neurol India"},{"issue":"3","key":"4040_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.24293","volume":"77","author":"X Peng","year":"2015","unstructured":"Peng X, Hughes EG, Moscato EH, Parsons TD, Dalmau J, Balice-Gordon, RJl. Cellular plasticity induced by anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol. 2015;77(3):381\u201398.","journal-title":"Ann Neurol"},{"issue":"19","key":"4040_CR13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","volume":"72","author":"B Joubert","year":"2015","unstructured":"Joubert B, Kerschen P, Zekeridou A, Desestret V, Rogemond V, Chaffois MO, et al. Clinical spectrum of encephalitis associated with antibodies against the \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature. JAMA Neurol. 2015;72(19):1163\u20139.","journal-title":"JAMA Neurol"},{"issue":"3","key":"4040_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0387-7604(02)00011-6","volume":"24","author":"M Hosoya","year":"2002","unstructured":"Hosoya M, Ushiku H, Arakawa H, Morikaw A, et al. Low-voltage activity in EEG during acute phase of encephalitis predicts unfavorable neurological outcome. Brain Dev. 2002;24(3):161\u20135.","journal-title":"Brain Dev"},{"issue":"19","key":"4040_CR15","doi-asserted-by":"publisher","first-page":"E529","DOI":"10.1503\/cmaj.181548","volume":"191","author":"A Budhram","year":"2019","unstructured":"Budhram A, Leung A, Nicolle MW, Burneo JG. Diagnosing autoimmune limbic encephalitis. CMAJ Can Med Assoc J. 2019;191(19):E529\u201334.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"1","key":"4040_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12883-021-02520-1","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Fan S, Ren H, Zhou L, Guan H. Clinical characteristics and prognosis of anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis. BMC Neurol. 2021;21(1):490.","journal-title":"BMC Neurol"},{"key":"4040_CR17","doi-asserted-by":"crossref","unstructured":"Spatola M, Stojanova V, Prior JO, Dalmau J, Rossetti AO. Serial Brain 18FDG-PET in anti-AMPA Receptor Limbic Encephalitis. J Neuro immunol. 2014;271(1\u20132): 53\u2009\u2013\u20095.","DOI":"10.1016\/j.jneuroim.2014.04.002"},{"issue":"9","key":"4040_CR18","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1097\/CCM.0000000000003278","volume":"46","author":"A Sakusic","year":"2018","unstructured":"Sakusic A, Sabov M, McCambridge AJ, Rabinstein AA, Singh TD, Mukesh K, et al. Features of adult hyperammonemia not due to liver failure in the ICU. CRIT CARE MED. 2018;46(9):e897\u2013903.","journal-title":"CRIT CARE MED"},{"issue":"4","key":"4040_CR19","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1378\/chest.06-2940","volume":"132","author":"AS Clay","year":"2007","unstructured":"Clay AS, Hainline BE. Hyperammonemia in the ICU. Chest. 2007;132(4):1368\u201378.","journal-title":"Chest"},{"issue":"6","key":"4040_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/WNF.0b013e3181ac3615","volume":"32","author":"SI Deutsch","year":"2009","unstructured":"Deutsch SI, Burket JA, Rosse RB. Valproate induced hyper ammonemic encephalopathy and normal liver functions: possible synergism with topiramate[J]. CLin Neuropharmacol. 2009;32(6):350\u20132.","journal-title":"CLin Neuropharmacol"},{"issue":"2","key":"4040_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1055\/s-0042-1744124","volume":"13","author":"R Verma","year":"2022","unstructured":"Verma R, Chakraborty R. An intractable case of Anti-N-methyl-D-aspartate receptor encephalitis with prolonged hyperammonemia. J Neurosci Rural Pract. 2022;13(2):354\u20136.","journal-title":"J Neurosci Rural Pract"},{"key":"4040_CR22","doi-asserted-by":"crossref","unstructured":"Llansola M, Rodrigo R, Monfort P, Montoliu C, Kosenko E, Cauli O et al. NMDA receptors in hyperammonemia and hepatic encephalopathy. Metab Brain Dis. 2007;22(3\u20134): 321\u2009\u2013\u200935.","DOI":"10.1007\/s11011-007-9067-0"},{"issue":"2","key":"4040_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glase C, Iizuka T, et al. Treatment and prognostic factors for long-term outcomein patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157\u201365.","journal-title":"Lancet Neurol"},{"issue":"12","key":"4040_CR24","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","volume":"15","author":"M Nosadini","year":"2015","unstructured":"Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune Therapy in Autoimmune Encephalitis: a systematic review. Expert Rev Neurother. 2015;15(12):1391\u2013419.","journal-title":"Expert Rev Neurother"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04040-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T11:36:14Z","timestamp":1738323374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04040-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04040-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that the study follows the tenants of the Declaration of Helsinki. For this case report, we obtained written consent from the patient to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient, s parent for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}